LifeStance Health Group, Inc. (LFST)

NASDAQ: LFST · Real-Time Price · USD

11.49

-0.41 (-3.45%)

Aug 11, 2026, 3:22 PM EDT - Market open

LifeStance Health Group Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	50.6	9.66	-57.44	-186.26	-215.56	-307.2
Depreciation & Amortization	54.56	54.75	70.95	80.44	69.2	54.14
Stock-Based Compensation	69.95	74.7	76.17	99.39	187.43	259.44
Other Adjustments	46.48	47.38	44.95	23.28	28.66	0.9
Change in Receivables	19.37	36.09	-6.4	-24.18	-21.66	-24.21
Changes in Accounts Payable	2.66	-1.56	0.5	-5.61	7.67	0.62
Changes in Accrued Expenses	19.69	19.94	28.61	36.69	13.66	54.85
Changes in Other Operating Activities	-47.86	-94.81	-50.08	-40.63	-16.6	-29.12
Operating Cash Flow	217.87	146.15	107.26	-16.88	52.79	9.42
Operating Cash Flow Growth	48.88%	36.26%	-	-	460.39%	-

Investing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Capital Expenditures	-43.96	-36.13	-21.57	-40.52	-79.26	-94.49
Cash Acquisitions	-9.04	-	-	-19.82	-60.21	-99.58
Investing Cash Flow	-53	-36.13	-21.57	-60.34	-139.46	-194.08

Financing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Long-Term Debt Issued	-	-	287.81	57.75	257.32	98.8
Long-Term Debt Repaid	-10.88	-7.25	-289.49	-2.47	-189.38	-320.21
Net Long-Term Debt Issued (Repaid)	-10.88	-7.25	-1.69	55.28	67.95	-221.41
Issuance of Common Stock	-	-	-	-	-	549.91
Repurchase of Common Stock	-97.63	-	-	-	-	-
Net Common Stock Issued (Repurchased)	-97.63	-	-	-	-	549.91
Other Financing Activities	-24.72	-8.71	-8.26	-7.86	-20.69	-14.64
Financing Cash Flow	-127.85	-15.96	-9.95	47.43	47.26	313.86

Net Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Cash Flow	37.01	94.07	75.75	-29.8	-39.41	129.2

Free Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Free Cash Flow	173.91	110.03	85.69	-57.4	-26.47	-85.07
Free Cash Flow Growth	44.84%	28.39%	-	-	-	-
FCF Margin	10.97%	7.72%	6.85%	-5.44%	-3.08%	-12.74%
Free Cash Flow Per Share	0.44	0.28	0.23	-0.16	-0.07	-0.26
Levered Free Cash Flow	24.81	-55.4	-30.71	-100.61	-152.95	-579.36
Unlevered Free Cash Flow	44.32	-38.93	-3.11	-140.16	-200	-278.08

SEC Filings: 10-K · 10-Q